Raising HDL cholesterol in women

References

• American Heart AssociationFacts about Women and Cardiovascular Diseases2008 Available from: http://www.americanheart.org/presenter.jhtml?identifier=2876. Accessed August 14, 2008.
   Google Scholar
• KuvinJTAlsheikh-AliAAKarasRHHigh-density lipoprotein cholesterol-raising strategiesJ Cardiovasc Pharmacol200647219620416495756
   PubMed Web of Science ®Google Scholar
• GoldbourtUMedalieJHHigh density lipoprotein cholesterol and incidence of coronary heart disease – the Israeli Ischemic Heart Disease StudyAm J Epidemiol19791093296308222135
   PubMed Web of Science ®Google Scholar
• CastelliWPCardiovascular disease in womenAm J Obstet Gynecol19881586 Pt 2155360156615573377033
   PubMed Web of Science ®Google Scholar
• BassKMNewschafferCJKlagMJBushTLPlasma lipoprotein levels as predictors of cardiovascular death in womenArch Intern Med199315319220922168215724
   PubMedGoogle Scholar
• WilsonPWAbbottRDCastelliWPHigh density lipoprotein cholesterol and mortality. The Framingham Heart StudyArteriosclerosis1988867377413196218
   PubMedGoogle Scholar
• von EckardsteinANoferJRAssmannGHigh density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transportArterioscler Thromb Vasc Biol2001211132711145929
   PubMed Web of Science ®Google Scholar
• LewisCEFunkhouserERaczynskiJMSidneySBildDEHowardBVAdverse effect of pregnancy on high density lipoprotein (HDL) cholesterol in young adult women. The CARDIA Study. Coronary Artery Risk Development in Young AdultsAm J Epidemiol199614432472548686693
   PubMed Web of Science ®Google Scholar
• GlomsetJAJanssenETKennedyRDobbinsJRole of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteinsJ Lipid Res1966756386484961566
   PubMed Web of Science ®Google Scholar
• ActonSRigottiALandschulzKTXuSHobbsHHKriegerMIdentification of scavenger receptor SR-BI as a high density lipoprotein receptorScience199627152485185208560269
   PubMed Web of Science ®Google Scholar
• BrewerHBJrIncreasing HDL Cholesterol LevelsN Engl J Med2004350151491149415071124
   PubMed Web of Science ®Google Scholar
• MorganJMCapuzziDMBakshRIEffects of extended-release niacin on lipoprotein subclass distributionAm J Cardiol200391121432143612804729
   PubMed Web of Science ®Google Scholar
• CockerillGWRyeKAGambleJRVadasMABarterPJHigh-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion moleculesArterioscler Thromb Vasc Biol19951511198719947583580
   PubMed Web of Science ®Google Scholar
• CockerillGWSaklatvalaJRidleySHHigh-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2Arterioscler Thromb Vasc Biol199919491091710195917
   PubMed Web of Science ®Google Scholar
• XiaPVadasMARyeKABarterPJGambleJRHigh density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDLJ Biol Chem199927446331433314710551885
   PubMed Web of Science ®Google Scholar
• YuhannaISZhuYCoxBEHigh-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthaseNat Med20017785385711433352
   PubMed Web of Science ®Google Scholar
• KuvinJTRametMEPatelARPandianNGMendelsohnMEKarasRHA novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expressionAm Heart J2002144116517212094204
   PubMed Web of Science ®Google Scholar
• FreedmanDSOtvosJDJeyarajahEJBarboriakJJAndersonAJWalkerJARelation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery diseaseArterioscler Thromb Vasc Biol1998187104610539672064
   PubMed Web of Science ®Google Scholar
• HuangYvon EckardsteinAWuSAssmannGCholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasmaArterioscler Thromb Vasc Biol1995159141214187670956
   PubMed Web of Science ®Google Scholar
• SalonenJTSalonenRSeppanenKRauramaaRTuomilehtoJHDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish menCirculation19918411291392060089
   PubMed Web of Science ®Google Scholar
• CastelliWPGarrisonRJWilsonPWAbbottRDKalousdianSKannelWBIncidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA1986256202835383773200
   PubMed Web of Science ®Google Scholar
• CastelliWPCholesterol and lipids in the risk of coronary artery disease – the Framingham Heart StudyCan J Cardiol19884Suppl A5A10A3282627
   PubMed Web of Science ®Google Scholar
• ShaiIRimmEBHankinsonSEMultivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelinesCirculation2004110182824283015492318
   PubMed Web of Science ®Google Scholar
• GordonDJProbstfieldJLGarrisonRJHigh-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studiesCirculation19897918152642759
   PubMed Web of Science ®Google Scholar
• WaldenCEKnoppRHWahlPWBeachKWStrandnessEJrSex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrationsN Engl J Med1984311159539596472421
   PubMed Web of Science ®Google Scholar
• PearsonTABulkleyBHAchuffSCKwiterovichPOGordisLThe association of low levels of HDL cholesterol and arteriographically defined coronary artery diseaseAm J Epidemiol19791093285295222134
   PubMed Web of Science ®Google Scholar
• MillerMSeidlerAKwiterovichPOPearsonTALong-term predictors of subsequent cardiovascular events with coronary artery disease and ‘desirable’ levels of plasma total cholesterolCirculation1992864116511701394924
   PubMed Web of Science ®Google Scholar
• Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• GordonTCastelliWPHjortlandMCKannelWBDawberTRHigh density lipoprotein as a protective factor against coronary heart disease. The Framingham StudyAm J Med1977625707714193398
   PubMed Web of Science ®Google Scholar
• CortiMCGuralnikJMSaliveMEHDL cholesterol predicts coronary heart disease mortality in older personsJAMA199527475395447629981
   PubMed Web of Science ®Google Scholar
• KalinMFZumoffBSex hormones and coronary disease: a review of the clinical studiesSteroids19905583303522237942
   PubMed Web of Science ®Google Scholar
• KafonekSDPostmenopausal hormone replacement therapy and cardiovascular risk reduction. A reviewDrugs199447Suppl 216247517830
   PubMed Web of Science ®Google Scholar
• StevensonJCCrookDGodslandIFInfluence of age and menopause on serum lipids and lipoproteins in healthy womenAtherosclerosis1993981838908457253
   PubMed Web of Science ®Google Scholar
• RazayGHeatonKWBoltonCHCoronary heart disease risk factors in relation to the menopauseQ J Med199285307–3088898961484951
   PubMedGoogle Scholar
• MatthewsKAMeilahnEKullerLHKelseySFCaggiulaAWWingRRMenopause and risk factors for coronary heart diseaseN Engl J Med1989321106416462488072
   PubMed Web of Science ®Google Scholar
• JensenJNilasLChristiansenCInfluence of menopause on serum lipids and lipoproteinsMaturitas19901243213312124647
   PubMed Web of Science ®Google Scholar
• JennerJLOrdovasJMLamon-FavaSEffects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring StudyCirculation1993874113511418462142
   PubMed Web of Science ®Google Scholar
• FolsomAREpidemiology of fibrinogenEur Heart J199516Suppl A2123discussion 23–24.7796826
   PubMed Web of Science ®Google Scholar
• UrabeMYamamotoTKashiwagiTEffect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly womenEndocr J19964367377429075616
   PubMed Web of Science ®Google Scholar
• PoehlmanETTothMJAdesPARosenCJMenopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal studyEur J Clin Invest19972743223269134381
   PubMed Web of Science ®Google Scholar
• PasqualiRCasimirriFPascalGInfluence of menopause on blood cholesterol levels in women: the role of body composition, fat distribution and hormonal milieu. Virgilio Menopause Health GroupJ Intern Med199724131952039104432
   PubMed Web of Science ®Google Scholar
• LipGYBlannADJonesAFBeeversDGEffects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosisAm Heart J199713447647719351746
   PubMed Web of Science ®Google Scholar
• LiZMcNamaraJRFruchartJCEffects of gender and menopausal status on plasma lipoprotein subspecies and particle sizesJ Lipid Res1996379188618968895054
   PubMed Web of Science ®Google Scholar
• ZagoVSanguinettiSBritesFImpaired high density lipoprotein antioxidant activity in healthy postmenopausal womenAtherosclerosis2004177120321015488885
   PubMed Web of Science ®Google Scholar
• SvenssonMChristensenJHSollingJSchmidtEBThe effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRFAm J Kidney Dis2004441778315211441
   PubMed Web of Science ®Google Scholar
• OkudaNUeshimaHOkayamaARelation of long chain n-3 poly-unsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID studyAtherosclerosis2005178237137915694947
   PubMed Web of Science ®Google Scholar
• EspositoKMarfellaRCiotolaMEffect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trialJAMA2004292121440144615383514
   PubMed Web of Science ®Google Scholar
• DallongevilleJYarnellJDucimetierePFish consumption is associated with lower heart ratesCirculation2003108782082512912821
   PubMed Web of Science ®Google Scholar
• ChrysohoouCPanagiotakosDBPitsavosCDasUNStefanadisCAdherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA StudyJ Am Coll Cardiol200444115215815234425
   PubMed Web of Science ®Google Scholar
• EstruchRMartinez-GonzalezMACorellaDEffects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trialAnn Intern Med2006145111116818923
   PubMed Web of Science ®Google Scholar
• BalkEMLichtensteinAHChungMKupelnickBChewPLauJEffects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic reviewAtherosclerosis20061891193016530201
   PubMed Web of Science ®Google Scholar
• FosterGDWyattHRHillJOA randomized trial of a low-carbohydrate diet for obesityN Engl J Med2003348212082209012761365
   PubMed Web of Science ®Google Scholar
• VolekJSSharmanMJGomezALScheettTPKraemerWJAn isoenergetic very low carbohydrate diet improves serum HDL cholesterol and triacylglycerol concentrations, the total cholesterol to HDL cholesterol ratio and postprandial pipemic responses compared with a low fat diet in normal weight, normolipidemic womenJ Nutr200313392756276112949361
   PubMed Web of Science ®Google Scholar
• SharmanMJKraemerWJLoveDMA ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight menJ Nutr200213271879188512097663
   PubMed Web of Science ®Google Scholar
• Yu-PothSZhaoGEthertonTNaglakMJonnalagaddaSKris-EthertonPMEffects of the National Cholesterol Education Program’s Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysisAm J Clin Nutr199969463264610197564
   PubMed Web of Science ®Google Scholar
• SchaeferEJLichtensteinAHLamon-FavaSEfficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and womenArterioscler Thromb Vasc Biol1995158107910857627699
   PubMed Web of Science ®Google Scholar
• KnoppRHParamsothyPRetzlaffBMGender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular diseaseCurr Atheroscler Rep20057647247916256006
   PubMedGoogle Scholar
• GazianoJMBuringJEBreslowJLModerate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarctionN Engl J Med199332925182918348247033
   PubMed Web of Science ®Google Scholar
• MukamalKJJensenMKGronbaekMDrinking frequency, mediating biomarkers, and risk of myocardial infarction in women and menCirculation2005112101406141316129796
   PubMed Web of Science ®Google Scholar
• RimmEBWilliamsPFosherKCriquiMStampferMJModerate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factorsBMJ199931972241523152810591709
   PubMed Web of Science ®Google Scholar
• GodslandIFLeyvaFWaltonCWorthingtonMStevensonJCAssociations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC-1)J Intern Med1998244133419698022
   PubMed Web of Science ®Google Scholar
• FanAZRussellMDornJLifetime alcohol drinking pattern is related to the prevalence of metabolic syndrome. The Western New York Health Study (WNYHS)Eur J Epidemiol200621212913816518681
   PubMed Web of Science ®Google Scholar
• SteinbergDPearsonTAKullerLHAlcohol and atherosclerosisAnn Intern Med1991114119679762024865
   PubMed Web of Science ®Google Scholar
• LieberCSAlcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosisAlcohol200434191915670660
   PubMed Web of Science ®Google Scholar
• HopkinsPNWilliamsRRA simplified approach to lipoprotein kinetics and factors affecting serum cholesterol and triglyceride concentrationsAm J Clin Nutr19813411256025907030050
   PubMed Web of Science ®Google Scholar
• DevenyiPRobinsonGMRoncariDAAlcohol and high-density lipoproteinsCan Med Assoc J1980123109819847004614
   PubMed Web of Science ®Google Scholar
• CriquiMHWallaceRBHeissGMishkelMSchonfeldGJonesGTCigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence StudyCirculation1980624 Pt 2IV70IV767418146
   PubMedGoogle Scholar
• GarrisonRJKannelWBFeinleibMCastelliWPMcNamaraPMPadgettSJCigarette smoking and HDL cholesterol: the Framingham offspring studyAtherosclerosis19783011725209795
   PubMed Web of Science ®Google Scholar
• MoffattRJEffects of cessation of smoking on serum lipids and high density lipoprotein-cholesterolAtherosclerosis1988741–285893214483
   PubMed Web of Science ®Google Scholar
• KelleyGAKelleyKSTranZVAerobic exercise and lipids and lipoproteins in women: a meta-analysis of randomized controlled trialsJ Womens Health (Larchmt)200413101148116415650348
   PubMed Web of Science ®Google Scholar
• MazzaliGDi FrancescoVZoicoEInterrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older womenAm J Clin Nutr20068451193119917093174
   PubMed Web of Science ®Google Scholar
• TayJBrinkworthGDNoakesMKeoghJCliftonPMMetabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjectsJ Am Coll Cardiol2008511596718174038
   PubMed Web of Science ®Google Scholar
• MillerMBeachVSorkinJDComparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenanceJ Am Diet Assoc2009109471371719328268
   PubMedGoogle Scholar
• AzoguiGBen-ShlomoIZoharSKookAPresserSAviramMHigh density lipoprotein concentration is increased during the ovulatory phase of the menstrual cycle in healthy young womenGynecol Endocrinol1992642532571492580
   PubMed Web of Science ®Google Scholar
• WinkelsteinWJrStencheverMALilienfeldAMOccurrence of pregnancy, abortion, and artificial menopause among women with coronary artery disease: a preliminary studyJ Chronic Dis19587427328613539140
   PubMedGoogle Scholar
• BengtssonCRyboGWesterbergHNumber of pregnancies, use of oral contraceptives and menopausal age in women with ischemic heart disease, compared to a population sample of womenActa Med Scand19735497581
   Google Scholar
• BeardCMFusterVAnnegersJFReproductive history in women with coronary heart disease. A case-control studyAm J Epidemiol198412011081146741912
   PubMed Web of Science ®Google Scholar
• HubertHBEakerEDGarrisonRJCastelliWPLife-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspringAm J Epidemiol198712558128313565356
   PubMed Web of Science ®Google Scholar
• HaertelUHeissGFilipiakBDoeringACross-sectional and longitudinal associations between high density lipoprotein cholesterol and women’s employmentAm J Epidemiol1992135168781736662
   PubMed Web of Science ®Google Scholar
• Kritz-SilversteinDBarrett-ConnorEWingardDLThe relationship between multiparity and lipoprotein levels in older womenJ Clin Epidemiol19924577617671619455
   PubMed Web of Science ®Google Scholar
• FlegalKMNessRBKramerRAParity and high density lipoprotein (HDL) cholesterol levels in white women from the Second National Health and Nutrition Examination Survey (NHANES II)Am J Epidemiol1990132766
   Web of Science ®Google Scholar
• MoscaLBankaCLBenjaminEJEvidence-based guidelines for cardiovascular disease prevention in women: 2007 updateCirculation2007115111481150117309915
   PubMedGoogle Scholar
• MoscaLAppelLJBenjaminEJEvidence-based guidelines for cardiovascular disease prevention in womenCirculation2004109567269314761900
   PubMed Web of Science ®Google Scholar
• International Atherosclerosis SocietyHarmonized clinical guidelines on prevention of atherosclerotic vascular disease [online] Available from: http://www.athero.org. Accessed on August 10, 2009
   Google Scholar
• SchaeferJRSchweerHIkewakiKMetabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery diseaseAtherosclerosis1999144117718410381291
   PubMed Web of Science ®Google Scholar
• DownsJRClearfieldMWeisSPrimary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention StudyJAMA199827920161516229613910
   PubMed Web of Science ®Google Scholar
• AthyrosVGMikhailidisDPPapageorgiouAAEffect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) StudyCurr Med Res Opin200420562763715171226
   PubMed Web of Science ®Google Scholar
• NissenSENichollsSJSipahiIEffect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trialJAMA2006295131556156516533939
   PubMed Web of Science ®Google Scholar
• BallantyneCMHerdJAFerlicLLInfluence of low HDL on progression of coronary artery disease and response to fluvastatin therapyCirculation19999967367439989957
   PubMed Web of Science ®Google Scholar
• PedersenTROlssonAGFaergemanOLipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)Circulation19989715145314609576425
   PubMed Web of Science ®Google Scholar
• BirjmohunRSHuttenBAKasteleinJJStroesESEfficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trialsJ Am Coll Cardiol200545218519715653014
   PubMed Web of Science ®Google Scholar
• BelalcazarLMBallantyneCMDefining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterolProg Cardiovasc Dis19984121511749790415
   PubMed Web of Science ®Google Scholar
• StaelsBDallongevilleJAuwerxJSchoonjansKLeitersdorfEFruchartJCMechanism of action of fibrates on lipid and lipoprotein metabolismCirculation19989819208820939808609
   PubMed Web of Science ®Google Scholar
• SakuKGartsidePSHyndBAKashyapMLMechanism of action of gemfibrozil on lipoprotein metabolismJ Clin Invest1985755170217123923042
   PubMed Web of Science ®Google Scholar
• PollinTIDamcottCMShenHA null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardio-protectionScience200832259081702170519074352
   PubMed Web of Science ®Google Scholar
• FruchartJCPeroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolismAm J Cardiol20018812A24N29N
   Google Scholar
• CorellaDGuillenMSaizCAssociations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locusJ Lipid Res200243341642711893778
   PubMed Web of Science ®Google Scholar
• RubinsHBRobinsSJCollinsDGemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study GroupN Engl J Med1999341641041810438259
   PubMed Web of Science ®Google Scholar
• RobinsSJCollinsDWittesJTRelation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trialJAMA2001285121585159111268266
   PubMed Web of Science ®Google Scholar
• FrickMHEloOHaapaKHelsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart diseaseN Engl J Med198731720123712453313041
   PubMed Web of Science ®Google Scholar
• OtvosJDCollinsDFreedmanDSLow-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention TrialCirculation2006113121556156316534013
   PubMed Web of Science ®Google Scholar
• KeechASimesRJBarterPEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialLancet200536695001849186116310551
   PubMed Web of Science ®Google Scholar
• AldermanJDPasternakRCSacksFMSmithHSMonradESGrossmanWEffect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratioAm J Cardiol198964127257292801522
   PubMed Web of Science ®Google Scholar
• GoldbergAAlagonaPJrCapuzziDMMultiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemiaAm J Cardiol20008591100110510781759
   PubMed Web of Science ®Google Scholar
• LavieCJMailanderLMilaniRVMarked benefit with sustained-release niacin therapy in patients with “isolated” very low levels of high-density lipoprotein cholesterol and coronary artery diseaseAm J Cardiol19926912108310851561983
   PubMed Web of Science ®Google Scholar
• MorganJMCapuzziDMGuytonJRTreatment Effect of Niaspan, a Controlled-release Niacin, in Patients With Hypercholesterolemia: A Placebo-controlled TrialJ Cardiovasc Pharmacol Ther19961319520210684417
   PubMedGoogle Scholar
• KnoppRHAlagonaPDavidsonMEquivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemiaMetabolism1998479109711049751239
   PubMed Web of Science ®Google Scholar
• GoldbergACA meta-analysis of randomized controlled studies on the effects of extended-release niacin in womenAm J Cardiol200494112112415219522
   PubMed Web of Science ®Google Scholar
• TaherTHDzavikVReteffEMPearsonGJWoloschukBLFrancisGATolerability of statin-fibrate and statin-niacin combination therapy in dyslipidemic patients at high risk for cardiovascular eventsAm J Cardiol200289439039411835917
   PubMed Web of Science ®Google Scholar
• BrownBGZhaoXQChaitASimvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary diseaseN Engl J Med2001345221583159211757504
   PubMed Web of Science ®Google Scholar
• KaneJPMalloyMJPortsTAPhillipsNRDiehlJCHavelRJRegression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimensJAMA199026423300730122243428
   PubMed Web of Science ®Google Scholar
• WalshBWSchiffIRosnerBGreenbergLRavnikarVSacksFMEffects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteinsN Engl J Med199132517119612041922206
   PubMed Web of Science ®Google Scholar
• BinderEFWilliamsDBSchechtmanKBJeffeDBKohrtWMEffects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trialAnn Intern Med20011349 Pt 175476011329233
   PubMed Web of Science ®Google Scholar
• RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• GradyDHerringtonDBittnerVCardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)JAMA20022881495712090862
   PubMed Web of Science ®Google Scholar
• de GroothGJKuivenhovenJAStalenhoefAFEfficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response studyCirculation2002105182159216511994249
   PubMed Web of Science ®Google Scholar
• BarterPJCaulfieldMErikssonMEffects of torcetrapib in patients at high risk for coronary eventsN Engl J Med200735721210922217984165
   PubMed Web of Science ®Google Scholar
• BloomfieldDCarlsonGLSapreAEfficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patientsAm Heart J20091572352360e35219185645
   PubMed Web of Science ®Google Scholar
• FranceschiniGSirtoriCRCapursoA2ndWeisgraberKHMahleyRWA-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian familyJ Clin Invest19806658929007430351
   PubMed Web of Science ®Google Scholar
• NissenSETsunodaTTuzcuEMEffect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trialJAMA2003290172292230014600188
   PubMed Web of Science ®Google Scholar
• ShahPKYanoJReyesOHigh-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilizationCirculation2001103253047305011425766
   PubMed Web of Science ®Google Scholar
• WangLSharifiBGPanTSongLYukhtAShahPKBone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic miceJ Am Coll Cardiol20064871459146817010811
   PubMed Web of Science ®Google Scholar
• TardifJCGregoireJL’AllierPLEffects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trialJAMA2007297151675168217387133
   PubMed Web of Science ®Google Scholar
• WangNLanDChenWMatsuuraFTallARATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteinsProc Natl Acad Sci U S A2004101269774977915210959
   PubMed Web of Science ®Google Scholar
• OramJFLawnRMABCA1. The gatekeeper for eliminating excess tissue cholesterolJ Lipid Res20014281173117911483617
   PubMed Web of Science ®Google Scholar